Metropolis Healthcare Ltd Share Price

Diagnostic Services

NSE: METROPOLIS Small Cap ISIN: INE112L01020

As on 22 January 2025 at 15:58 IST

₹1,849.55

+ 3.30

(0.18%)

Sell Buy

About Metropolis Healthcare Ltd

Metropolis Healthcare Ltd is a leading diagnostics service provider in India, specializing in pathology and radiology investigations. It operates in the healthcare sector. The company was founded in 1980. Metropolis Healthcare has decades of experience in the diagnostics field. The company's headquarters is located in Mumbai, Maharashtra, India. Metropolis Healthcare's main products and services include a variety of diagnostic tests and health packages. The company focuses on high-demand diagnostic categories such as gastroenterology and infectious diseases. Additionally, Metropolis offers wellness and illness-specific packages under its "True Health" portfolio, which has shown significant growth. Read More...

Over 1 Month

-8.68%

Over 6 Months

-9.26%

Over 1 Year

16.70%

Over 3 Years

-30.55%

Metropolis Healthcare Ltd Summary

Close ₹ 1,849.55

Open ₹ 1,840.85

High ₹ 1,860.20

Low ₹ 1,828.05

Volume 93,929

Net Turnover (in ₹) ₹ 12,19,98,124.40

52Wk High ₹ 2,318.30

52Wk Low ₹ 1,545.20

52Wk High / Low

1,545.20

2,318.30

Metropolis Healthcare Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 9,465.23

EPS (TTM) 25.75

Book Value (BV) 215.70

Div. Yield 0.22 %

P/E (TTM) 71.50

Price/Book Value 8.54

Delivery % 31.62 %

Face Value 2

Key Ratios

PE Ratio 76.32

PB Ratio 8.58

EV to Sales 8.16

PEG Ratio -4.59

ROA 9.33

ROE 11.78

Debt-Equity 0.24

Net Profit Margin 10.50

Operating Profit Margin 24.96

Metropolis Healthcare Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,216.83	1,163.43	1,245.96	1,010.03	864.97
Total Expenses	1,042.14	975.93	968.51	765.71	671.19
Profit Before Tax	174.69	187.50	293.35	244.32	168.73
Profit After Tax	128.46	143.39	214.69	183.35	127.55
Operating Profit after Depreciation	197.22	214.30	297.19	252.10	202.12

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	1,177.06	1,140.18	1,064.71	343.11	299.36
Total Non Current Assets	1,239.23	1,198.87	1,137.17	395.96	355.17
Total Current Assets	315.83	302.73	393.12	608.46	397.06
TOTAL ASSETS	1,555.06	1,501.61	1,530.29	1,004.41	752.23
Total Shareholder's Fund	1,096.16	988.23	886.20	706.60	523.50

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	264.07	247.09	253.27	249.03	215
Net Cash used in Investing Activities	-89.09	48.09	-736.41	63.08	-103.87
Net Cash used in Financing Activities	-181.20	-292.33	162.52	-32.69	-55.32

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,115.42	1,087.32	1,173.16	973.69	694.62
Total Expenses	958.01	908.38	917.51	731.57	530.11
Profit Before Tax	157.41	178.95	271.55	242.13	139.99
Profit After Tax	115.89	138.95	199.53	182.65	112.05
Operating Profit after Depreciation	179.75	205.64	275.25	249.80	171.08

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	1,120.09	1,085.28	1,010.51	307.09	218.77
Total Non Current Assets	1,200.26	1,168.86	1,105.36	353.22	386.23
Total Current Assets	272.44	265.44	353.18	585.90	302.07
TOTAL ASSETS	1,472.70	1,434.29	1,458.54	939.12	688.30
Total Shareholder's Fund	1,031.19	936.02	839.21	664.81	512.38

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	269.01	237.74	244.04	236.23	156.13
Net Cash used in Investing Activities	-81.51	46.72	-736.21	59.42	-51.13
Net Cash used in Financing Activities	-183	-287.87	171.97	-31.27	-46.37

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	349.79	313.36	331	291.12	308.50
Total Expenses	259.91	234.54	251.02	226.27	233.69
Profit Before Tax	61.40	51.09	50.53	36.86	48.11
Profit After Tax	46.70	38.11	36.53	27.29	35.66
Operating Profit after Depreciation	93.01	81.28	82.52	67.16	76.03

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	321.57	286.14	292.27	269.41	285.46
Total Expenses	239.55	217.87	218.34	210.58	217.98
Profit Before Tax	54.87	41.73	45.06	34.64	42.50
Profit After Tax	42.26	31.28	31.78	26.70	31.28
Operating Profit after Depreciation	85.61	71.10	75.95	64.02	69.49

Metropolis Healthcare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,816.88

S2 1,787.52

S3 1,740.83

Pivot 1,863.57

R1 1,892.93

R2 1,939.62

R3 1,968.98

Moving Average

20 SMA 1,977.03

50 SMA 2,065.45

100 SMA 2,119.11

200 SMA 2,033.49

Metropolis Healthcare Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 17 Aug 2022

AGM 17/08/2022 Metropolis Healthcare Limited has informed the Exchange that the 22nd Annual General Meeting ('AGM') of the Company is scheduled to be held on Wednesday, August 17, 2022 through Video conferencing ('VC') / Other Audio Visual Means ('OAVM'), accordingly the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, August 11, 2022 to Wednesday, August 17, 2022 (both the days inclusive) for taking on record the members of the Company for the purpose of holding the aforesaid AGM (As Per BSE Announcement dated on 19.07.2022) Dear Sir/ Madam, In continuation to our letter bearing reference No. MHL/Sec&Legal/2022-23/36 intimating the date of the 22nd Annual General Meeting (AGM) of the Company, please find attached herewith a copy of Annual Report for the Financial year 2021-22 along with the Notice of the 22nd AGM scheduled on Wednesday, August 17, 2022 at 09:30 a.m. (IST) through video-conferencing / other audio-visual means. Further, the Notice of the 22nd AGM and Annual Report for Financial year 2021-22 have also been made available on the website of the Company at www.metropolisindia.com and the Company has commence the dispatch of Notice of the AGM along with Annual Report for Financial year 2021-22 to the Members by electronic means on the email addresses as registered with the Company /Registrar and Share Transfer Agent/ Depository Participant(s), in compliance with relevant circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India. (As Per BSE Announcement dated on 26.07.2022) Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements pertaining to intimation of Closure of Register of Members and Share Transfer Books published in the following newspapers: 1. Free Press Journal (English Newspaper) 2. NavShakti (Marathi Newspaper) This is for your information and record. (As per BSE Announcement Dated on 05/08/2022) Dear Sir/Ma''am, Pursuant to Regulation 44 of the SEBI Listing Regulations and Section 108 of the Act read with Rules made thereunder, we enclose herewith the details of voting results along with the consolidated Scrutinizers' Report on remote e voting and e-voting. (As Per BSE Announcement Dated on 18.08.2022)

AGM Date: 17 Aug 2023

This is to inform you that 23rd Annual General Meeting ('AGM') of the Company is scheduled to be held on Thursday, August 17, 2023 through Video conferencing (''VC'')/ Other Audio Visual Means (''OAVM''). Further, the Register of Members and and Share transfer Books of the Company will remain closed from Friday, August 11, 2023 to Thursday, August 17, 2023 (both the days inclusive) for taking on record the members of the Company. Please find enclosed the Annual Report for the Financial Year 2022-23 Please find attached Notice of AGM for FY 2022-23 to be held on August 17, 2023 at 4.30 pm. (As Per BSE Announcement Dated on 25.07.2023) Please find enclosed herewith Voting results and a copy of Scrutinizer report of Annual General Meeting held on August 17, 2023. (As Per BSE Announcement dated on 21.08.2023)

AGM Date: 21 Aug 2024

AGM 21/08/2024 Proceedings of the 24th Annual General Meeting of the Company (As per BSE Announcement Dated on 21/08/2024)

Metropolis Healthcare Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Metropolis Healthcare Ltd	₹1,841.10	₹9,438.83
Max Healthcare Institute Ltd	₹1,078.10	₹1,04,805.56
Apollo Hospitals Enterprise Ltd	₹6,918.65	₹99,479.57
Fortis Healthcare Ltd	₹639.80	₹48,302.22
Syngene International Ltd	₹832.10	₹33,495.10
Global Health Ltd	₹1,055.75	₹28,356.11

Metropolis Healthcare Ltd News

Metropolis Healthcare allots 13,788 equity shares under RSUP

13 Jan 2025, 09:46 am

Metropolis Healthcare gains on strong Q3 biz update

Metropolis Healthcare shares climbed 2.27% to Rs 2,038 after the company announced double-digit revenue growth for Q3FY25, despite it being a seasonally slow period for diagnostics.

06 Jan 2025, 01:42 pm

Metropolis Healthcare incorporates subsidiary in Maharashtra

Metropolis Healthcare has announced the incorporation of Metropolis Clinical Pathology as a wholly owned subsidiary, effective from 25 December 2024.

26 Dec 2024, 02:36 pm

Metropolis Healthcare incorporates WoS Metropolis Clinical Pathology

26 Dec 2024, 09:46 am

Stock Alert: Metropolis Healthcare, Bharat Electronics, NHPC, Lemon Tree Hotels

10 Dec 2024, 08:32 am

Metropolis Healthcare Ltd Stock Analysis

Annual revenue for Metropolis Healthcare Ltd increased by 2.58% to ₹1,115.42 crore in FY 2024 from ₹1,087.32 crore in FY 2023.
Annual Net Profit for Metropolis Healthcare Ltd decreased by 16.59% to ₹115.89 crore in FY 2024 from ₹138.95 crore in FY 2023.
Promoter Shareholding in Metropolis Healthcare Ltd decreased by 0.05% in the most recent quarter, from 49.43% in September 2024 to 49.40% in December 2024.
Metropolis Healthcare Ltd delivered a 1-year return of 16.70% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Metropolis Healthcare Ltd share price moved up by 0.18% from its previous close of INR ₹1,846.25. The latest Metropolis Healthcare Ltd share price is INR ₹1,849.55.
Metropolis Healthcare Ltd share price today has been at a low of 1,828.05 and a high of 1,860.20. Over the past 52 weeks, the Metropolis Healthcare Ltd share price has seen a low of 1,545.20 and a high of 2,318.30.

About Metropolis Healthcare Ltd

Metropolis Healthcare Ltd is a leading diagnostics service provider in India. It specializes in pathology and radiology investigations. The company provides a wide range of diagnostic tests and services. These include biochemistry, haematology, histopathology, microbiology, immunology, virology, and more. Metropolis Healthcare operates in the healthcare sector, specifically within the diagnostics and medical services industry.

Founded in 1980 by Dr. Sushil Kanubhai Shah, Metropolis Healthcare has decades of experience in the diagnostics field. The company's headquarters is located in Mumbai, Maharashtra, India. Over the years, Metropolis has significantly expanded its presence. It now operates 124 clinical laboratories and over 2,400 collection centres across seven countries, including India, Sri Lanka, Uganda, Zambia, Kenya, Mauritius, and Ghana.

The promoters of the company include Metz Advisory LLP, with a 30.62% stake. Under their leadership, the company has expanded from a single diagnostic laboratory into a multinational chain. A team of managerial promoters manage the operations of the company. They are

Sushil Kanubhai Shah
Ameera Sushil Shah
Hemant Sachdev
Vivek Gambhir
Sanjay Bhatnagar

Metropolis Healthcare's main products and services include a variety of diagnostic tests and health packages. The company focuses on diagnostic categories with high demand. These include gastroenterology, neurology, oncology, and infectious diseases. Additionally, Metropolis offers wellness and illness-specific packages under its "True Health" portfolio. This segment has shown significant growth over time.

While Metropolis Healthcare is a prominent player in the diagnostics industry, it is not the largest in terms of market share or capitalization. However, the company continues to expand its reach and enhance its service offerings to improve patient outcomes and drive long-term growth.

The registered office of Metropolis Healthcare is in Worli, Mumbai. Meanwhile the office of the registrars is in Vikhroli, Mumbai. Metropolis Healthcare's commitment to quality and innovation has positioned it as a trusted name in the diagnostics industry, continually striving to provide accurate and timely diagnostic services to its customers.

The vision of the Metropolis Healthcare Limited

Metropolis Healthcare Ltd envisions a future where quality healthcare is accessible to everyone. The company aims to be a leader in the diagnostics industry, providing accurate and timely diagnostic services. A commitment to innovation and patient-centric care drives this vision of the company.

The company believes in the power of technology to transform healthcare. Metropolis Healthcare invests in state-of-the-art diagnostic equipment and advanced laboratory practices. This ensures that patients receive the most accurate test results. The company also focuses on continuous improvement and adopts the latest advancements in medical science.

Metropolis Healthcare's vision includes expanding its reach to underserved areas. The company aims to make diagnostic services available in remote and rural regions. This is achieved through a network of collection centres and partnerships with local healthcare providers. The goal is to bridge the gap in healthcare access and improve health outcomes for all.

The company places a strong emphasis on quality and reliability. Metropolis Healthcare adheres to stringent quality control measures and international standards. This commitment to quality is reflected in the company's accreditation by global healthcare organizations. Patients can trust that they are receiving the highest standard of care.

Metropolis Healthcare also envisions a future where preventive healthcare is prioritized. The company offers a range of wellness packages and health check-ups. These services help in early detection and management of diseases. The focus is on promoting a healthy lifestyle and preventing illnesses before they become serious.

The company values its employees and believes in fostering a positive work environment. Metropolis Healthcare invests in the professional development of its staff. This includes regular training programs and opportunities for career growth. The company recognizes that a motivated and skilled workforce is essential to achieving its vision.

Metropolis Healthcare is committed to sustainability and social responsibility. The company implements eco-friendly practices in its operations. This includes reducing waste and minimizing its carbon footprint. The company also engages in community outreach programs and supports various social causes.

The vision of Metropolis Healthcare is about more than business growth. It is about making a positive impact on society. The company aims to be a trusted partner in healthcare, contributing to the well-being of communities. This holistic approach sets Metropolis Healthcare apart in the diagnostics industry.

The company believes in the importance of patient education. Metropolis Healthcare provides resources and information to help patients make informed decisions about their health. This includes educational materials and online resources. The goal is to empower patients to take control of their health and well-being.

Metropolis Healthcare's vision includes leveraging digital technology to enhance patient experience. The company offers online booking and digital reports. These services provide convenience and ease of access for patients. As a result, the company has made healthcare more patient-friendly and efficient.

Metropolis Healthcare envisions a future where healthcare is personalized. The company offers customized health packages based on individual needs. This personalized approach ensures that patients receive the most relevant and effective care. The company aims to provide a tailored healthcare experience for each patient.

The company values transparency and ethical practices. Metropolis Healthcare operates with integrity and honesty. The company ensures that all its practices are ethical and transparent. This builds trust with patients and stakeholders.